These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 1170051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH, Townsend K, Michael AF.
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [Abstract] [Full Text] [Related]

  • 6. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ, Gazzinelli G, Pellegrino J, Dias de Silva W.
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract] [Full Text] [Related]

  • 7. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM, Bryan CS, Hawiger J, Colley DG.
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [Abstract] [Full Text] [Related]

  • 8. [Complement activation and biological activities].
    Inoue K.
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
    Brade V, Bentley C, Bitter-Suermann D, Hadding U.
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
    Spitzer R, Stitzel A, Florio L, Urmson J.
    Immunochemistry; 1976 May; 13(5):395-400. PubMed ID: 780264
    [No Abstract] [Full Text] [Related]

  • 14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 15. Activation of the complement and properdin systems in rheumatoid arthritis.
    Ruddy S, Austen KF.
    Ann N Y Acad Sci; 1975 Jun 13; 256():96-104. PubMed ID: 1099964
    [Abstract] [Full Text] [Related]

  • 16. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V, Beuscher HU.
    Immunobiology; 1984 Mar 13; 166(2):177-89. PubMed ID: 6724636
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structure and activation of the early components of complement.
    Porter RR.
    Fed Proc; 1977 Aug 13; 36(9):2191-6. PubMed ID: 328305
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.